Jane Street Group, LLC Cure Vac N.V. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$14.73 - $35.25 $478,725 - $1.15 Million	-32,500 Reduced 62.02%	19,900 $387,000
Q4 2021 Feb 15, 2022	SELL	$33.72 - $48.22 $1.19 Million - $1.71 Million	-35,400 Reduced 40.32%	52,400 $1.81 Million
Q3 2021 Nov 16, 2021	SELL	$49.26 - $74.5 $14.6 Million - $22.1 Million	-296,100 Reduced 77.13%	87,800 $4.81 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $16.9 Million - $37.8 Million	296,500 Added 339.24%	383,900 $28.2 Million
Q1 2021 May 18, 2021	BUY	$79.79 - $126.29 $694,173 - $1.1 Million	8,700 Added 11.05%	87,400 $7.99 Million
Q4 2020 Feb 17, 2021	BUY	$46.76 - $136.27 $3.13 Million - $9.13 Million	67,000 Added 572.65%	78,700 $6.38 Million
Q3 2020 Nov 17, 2020	BUY	$43.8 - $77.2 $512,459 - $903,240	11,700 New	11,700 $545,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.